Ledger.Open graph →
SEC Form D · filed February 10, 2022

Cytonus Therapeutics, Inc

Offering
$1.0M
Sold
$15K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
COLUMBUS, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Richard Klemke · Columbus, OHDirectorManisha Narasimhan · Columbus, OHDirectorChristopher Thorne · Columbus, OHDirectorRemo Moomiaie · Columbus, OHExec · DirectorIan R. Simm · London, United KingdomDirectorSarah Marriott · San Francisco, CAExec · DirectorParent of the General Partner Richard Impax Asset Management Group PLC · London, United KingdomDirectorKen Johnson · Mt. Laurel, NJDirectorDavid E. Finley · Boston, MAExec · DirectorKirsten P. Morin · Boston, MADirectorPeter W. Mooradian · Boston, MADirectorBenjamin T. Rubin · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗